RAPID ASSIST Rescue Services

Thanks to India's unique regulatory and demographic environment, DiagnoSearch Life Sciences can help you get back on track.

Fast Rescue Study Start-up
A new initiative of the India regulatory authority makes it possible to start your study in India within 6 weeks. This directive applies to any study that is currently approved and under way in the United States, the European Union, Japan, or another developed country.

Access to Thousands of Patients
With a population exceeding 1 billion people and a well developed healthcare infrastructure, India has plenty of patients in virtually all therapeutic areas and indications.

In particular, India has a high prevalence of diabetes, cardiovascular disease, hepatitis, cancer, CNS indications, and infectious diseases. For most diseases the standard of care matches that in Western countries, including the same diagnostic tools and drugs. Still, because of lower health awareness, many "treatment-naïve" patients can also be found in all indications. Subpopulations that are rare in the United States, such as patients with unresectable tumors, may be accessed in India.

DiagnoSearch Life Sciences works with approximately 700 GCP-trained investigators encompassing all the indications listed. For chronic diseases, these sites maintain active patient databases.

FDA-Quality Data
Since 1996, DiagnoSearch Life Sciences has managed more than 125 Phase I-IV clinical trials for international companies ranging from small biotech to large pharma. More than 85 of these clinical trials contributed Indian data to global submissions. In many of them DiagnoSearch Life Sciences provided the recruitment boost required to complete the study.